1-3 of 3
Lakshmanan Krishnamurti
Close
Sort by
Journal Articles

Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease

Lakshmanan Krishnamurti, Jingchen Liang, Zili He, Yanhong Deng, Vineetha R. Nallagatla, Rohaum Hamidi, Aron Flagg, Niketa Shah
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1908–1919.
https://doi.org/10.1182/bloodadvances.2023010749
Published: 2024
Includes: Supplemental data
Journal Articles

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children

Michelle Schoettler, Elizabeth Stenger, Kathleen Spencer, Deborah Lutterman, Savanah Rumbika, Jayre Jones, Ann Haight, Suhag Parikh, Muna Qayed, Benjamin Watkins, Lakshmanan Krishnamurti, Kirsten M. Williams, Satheesh Chonat
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1784–1795.
https://doi.org/10.1182/bloodadvances.2022008058
Published: 2023
Includes: Supplemental data
Journal Articles

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings

Ann T. Farrell, Julie Panepinto, Ankit A. Desai, Adetola A. Kassim, Jeffrey Lebensburger, Mark C. Walters, Daniel E. Bauer, Rae M. Blaylark, Donna M. DiMichele, Mark T. Gladwin, Nancy S. Green, Kathryn Hassell, Gregory J. Kato, Elizabeth S. Klings, Donald B. Kohn, Lakshmanan Krishnamurti, Jane Little, Julie Makani, Punam Malik, Patrick T. McGann, Caterina Minniti, Claudia R. Morris, Isaac Odame, Patricia Ann Oneal, Rosanna Setse, Poornima Sharma, Shalini Shenoy
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4002–4020.
https://doi.org/10.1182/bloodadvances.2019000883
Published: 2019
Includes: Supplemental data